Jie Huang

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Ranjana H. Advani, Ian W. Flinn, Leslie Popplewell et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik et al. · Journal of Clinical Oncology · 2019 · 590 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion

Nian Jiang, Bowen Xie, Wenwu Xiao et al. · Nature Communications · 2022 · 245 citations · Full text

Medicine, Oncology, Radiation Oncology +17

CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer

Shujun Han, Ryan Wei, Xiaodi Zhang et al. · Frontiers in Oncology · 2019 · 169 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells

Demet Candas-Green, Bowen Xie, Jie Huang et al. · Nature Communications · 2020 · 147 citations · Full text

Medicine, Oncology, Radiation Oncology +17